Pharmacuetical companies puzzled by new EU vaccine criteria
The EU Commission will invest in six projects to speed up the process of finding a corona vaccine, but risks limiting itself, as politics may play into the criteria.
.jpg)
BY LOUISE WENDT JENSEN, TRANSLATED BY CATHERINE BRETT
Henrik Vestergaard, deputy CEO of The Danish Association of the Pharmaceutical Industry (Lif) says that it would be "decidedly stupid" if the rumor that the EU is not willing to invest in companies that only have vaccine production in the USA when hunting for a corona vaccine was true.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
